These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 206853

  • 1. Effects of hypothalamic lesions and drugs interfering with dopaminergic transmission on pituitary MSH content of rats.
    Tilders FJ, Smelik PG.
    Neuroendocrinology; 1978; 25(5):275-90. PubMed ID: 206853
    [Abstract] [Full Text] [Related]

  • 2. An improved radioimmunoassay for alpha-melanocyte-stimulating hormone (alpha-MSH) in the rat: serum and pituitary alpha-MSH levels after drugs which modify catecholaminergic neurotransmission.
    Penny RJ, Thody AJ.
    Neuroendocrinology; 1978; 25(4):193-203. PubMed ID: 206851
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The effect of hypothalamic lesions on immuno-reactive alpha-melanocyte stimulating hormone secretion in the rat.
    Penny RJ, Tilders FJ, Thody AJ.
    J Physiol; 1979 Jul; 292():59-67. PubMed ID: 490393
    [Abstract] [Full Text] [Related]

  • 6. Dopaminergic and beta-adrenergic receptor control of alpha-melanocyte-stimulating hormone secretion during stress.
    Lindley SE, Lookingland KJ, Moore KE.
    Neuroendocrinology; 1990 Jul; 52(1):46-51. PubMed ID: 2168526
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Catecholaminergic control of alpha-melanocyte-stimulating hormone (alpha MSH) release by frog neurointermediate lobe in vitro: evidence for direct stimulation of alpha MSH release by thyrotropin-releasing hormone.
    Tonon MC, Leroux P, Stoeckel ME, Jegou S, Pelletier G, Vaudry H.
    Endocrinology; 1983 Jan; 112(1):133-41. PubMed ID: 6401174
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Evidence for a possible dopaminergic control of pituitary alpha-MSH during ontogenesis in mice.
    Schmitt G, Stoeckel ME, Koch B.
    Neuroendocrinology; 1981 Nov; 33(5):306-11. PubMed ID: 6272149
    [Abstract] [Full Text] [Related]

  • 13. Secretion of melanocyte-stimulating hormone and adrenocorticotropin from transplanted pituitary pars intermedia in stressed and nonstressed rats.
    Iturriza FC, Eberle AN.
    Neuroendocrinology; 1989 Jun; 49(6):610-6. PubMed ID: 2549438
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. MSH activity in pituitaries of rats treated with hypothalamic extracts.
    Kastin AJ, Schally AV.
    Gen Comp Endocrinol; 1966 Dec; 7(3):452-6. PubMed ID: 5962647
    [No Abstract] [Full Text] [Related]

  • 20. Identification of MSH release-inhibiting elements in the neurointermediate lobe of the rat.
    Tilders FJ, van der Woude HA, Swaab DF, Mulder AH.
    Brain Res; 1979 Aug 10; 171(3):425-35. PubMed ID: 38880
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.